Rocuronium Bromide
NDC 43066-013, Rocuronium Bromide, injection, from Baxter Healthcare Corporation.
- Product NDC
- 43066-013
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091115
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43066-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROCURONIUM BROMIDE100 mg/10mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43066-013-10 | 43066001310 | 10 VIAL in 1 CARTON (43066-013-10) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/31e15c3f-aefa-4379-b684-7707744fe40d
Use it
Look up 43066-013 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43066-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43066-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.